| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/10/1997 | US5637492 Activatable fibrinolytic and anti-thrombotic proteins |
| 06/10/1997 | US5637481 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 06/10/1997 | US5637480 DNA molecules encoding bone morphogenetic protein-10 |
| 06/10/1997 | US5637479 Genetic engineering |
| 06/10/1997 | US5637471 Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids |
| 06/10/1997 | US5637470 Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel |
| 06/10/1997 | US5637455 HIV-2 virus variants |
| 06/10/1997 | US5637454 Assays and treatments of autoimmune diseases |
| 06/10/1997 | US5637324 Medical food composition for metabolic detoxification |
| 06/10/1997 | US5637323 Administering interleukin |
| 06/10/1997 | US5637321 Water insoluble collagen |
| 06/10/1997 | US5637318 Increased oxygen penetration of skin |
| 06/10/1997 | US5637317 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same |
| 06/10/1997 | US5637309 Including carrier composed of combination of cellulose ether or crystalline cellulose with fat, oil, wax, fatty acid, saccharide and/or polyacrylate ester; for intrathecal implantation |
| 06/10/1997 | US5637304 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use |
| 06/10/1997 | US5637300 Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception |
| 06/10/1997 | US5637299 Enhancement of thrombolytic therapy with deglycosylated forms of plasminogen |
| 06/10/1997 | CA2122835C Polymer-based osmotic drug delivery system |
| 06/10/1997 | CA2109958C Calcium, trace mineral, vitamin d and drug therapy combinations |
| 06/05/1997 | WO1997020218A1 Calcium channel modulator compositions and methods |
| 06/05/1997 | WO1997020077A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 06/05/1997 | WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
| 06/05/1997 | WO1997020062A1 Il-12 p40 subunit fusion polypeptides and uses thereof |
| 06/05/1997 | WO1997020052A1 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
| 06/05/1997 | WO1997020051A2 Vectors and methods for gene transfer to cells |
| 06/05/1997 | WO1997020049A1 Human peptide circulating in the blood and possessing insulinotropic properties |
| 06/05/1997 | WO1997020047A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | WO1997020045A2 P2u2 PURINERGIC RECEPTOR |
| 06/05/1997 | WO1997020036A1 Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines |
| 06/05/1997 | WO1997020031A2 Rna polymerase ii carboxyl terminal domain-derived peptides |
| 06/05/1997 | WO1997019957A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 06/05/1997 | WO1997019956A1 Method for control of functionality during cross-linking of hemoglobins |
| 06/05/1997 | WO1997019954A1 Targeted cytotoxic anthracycline analogs |
| 06/05/1997 | WO1997019953A2 New lh-rh antagonists with improved effectiveness |
| 06/05/1997 | WO1997019952A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | WO1997019911A1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 06/05/1997 | WO1997019704A1 Smooth muscle cell-derived migration factor |
| 06/05/1997 | WO1997019698A1 Diphtheria toxin epitopes |
| 06/05/1997 | WO1997019697A1 Method of using beta-interferons to treat restenosis |
| 06/05/1997 | WO1997019696A1 C-c chemokines that inhibit retrovirus infection |
| 06/05/1997 | WO1997019695A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019694A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019693A1 Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019692A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | WO1997019690A1 Stable vancomycin hydrochloride solutions |
| 06/05/1997 | WO1997019687A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | WO1997019686A1 Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis |
| 06/05/1997 | WO1997019681A1 Perfluoroalkyl substituted metallo-beta-lactamase inhibitors and method for the preparation of trifluoromethylketone derivatives |
| 06/05/1997 | WO1997019676A1 Method of producing morphologically uniform microcapsules and microcapsules produced by this method |
| 06/05/1997 | WO1997013858A3 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |
| 06/05/1997 | WO1997012036A3 Bone stimulating factor |
| 06/05/1997 | WO1997010851A3 Nucleic acid delivery vehicle |
| 06/05/1997 | WO1997010334A3 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 06/05/1997 | WO1997009973A3 Peripherally active anti-hyperalgesic opiates |
| 06/05/1997 | WO1997007219A3 Genes and proteins controlling cholesterol synthesis |
| 06/05/1997 | DE19651001A1 Mammalian VAT1-homologous protein, derived peptide(s), antibodies and cDNA |
| 06/05/1997 | DE19545044A1 Endoparasitizide Mittel Endoparasiticides means |
| 06/05/1997 | DE19544687A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
| 06/05/1997 | DE19544507A1 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations |
| 06/05/1997 | DE19544212A1 Neue LH-RH-Antagonisten mit verbesserter Wirkung New LH-RH antagonists with improved activity |
| 06/05/1997 | CA2239206A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | CA2239012A1 Diphtheria toxin epitopes |
| 06/05/1997 | CA2238944A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | CA2238872A1 Stable vancomycin hydrochloride solutions |
| 06/05/1997 | CA2238829A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | CA2238770A1 Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis |
| 06/05/1997 | CA2238579A1 Smooth muscle cell-derived migration factor |
| 06/05/1997 | CA2238570A1 New lh-rh antagonists with improved effectiveness |
| 06/05/1997 | CA2238569A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | CA2237937A1 Novel purinergic receptor |
| 06/05/1997 | CA2237716A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 06/05/1997 | CA2236794A1 Method for control of functionality during cross-linking of hemoglobins |
| 06/05/1997 | CA2236157A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
| 06/04/1997 | EP0776980A1 Evaluation of substances for altering and for increasing APC response |
| 06/04/1997 | EP0776969A2 Process to prepare proteins by controlled proteolysis of pro-proteins |
| 06/04/1997 | EP0776907A2 Process for producing platelet factor-4 |
| 06/04/1997 | EP0776906A2 Sm-D peptide antigens and their use especially in the diagnosis of systemic lupus erythromatodes |
| 06/04/1997 | EP0776370A1 Human erythropoietin receptor fragment and antibodies thereto |
| 06/04/1997 | EP0776366A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 06/04/1997 | EP0776365A2 Retinoblastoma protein-interacting zinc finger proteins |
| 06/04/1997 | EP0776361A1 Recombinant herpesvirus of turkeys and uses thereof |
| 06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
| 06/04/1997 | EP0776338A1 Immunoconjugates comprising tyrosine kinase inhibitors |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776336A1 Vitronectin binding protein |
| 06/04/1997 | EP0776334A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 06/04/1997 | EP0776333A1 Peptide antagonist intermediates of neurotensin |
| 06/04/1997 | EP0776332A1 NEW PEPTIDE DERIVATIVES WITH $g(d) OPIOID RECEPTOR ANTAGONIST OR MIXED $g(m) AGONIST/$g(d) ANTAGONIST EFFECTS |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776218A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 06/04/1997 | EP0776217A1 A method of treating a patient with a biologically active compound |
| 06/04/1997 | EP0776216A1 Dual carrier immunogenic construct |
| 06/04/1997 | EP0776215A1 Device for delivery of substances and methods of use thereof |
| 06/04/1997 | EP0776214A1 Antibacterial composition containing multimeric alpha-lactalbumin |
| 06/04/1997 | EP0776213A1 Method of treating hypertension in pregnant mammals |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0776209A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 06/04/1997 | EP0776175A1 Therapeutic homeopathic dilutions of growth factors and methods of their use |
| 06/04/1997 | EP0776163A1 Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases |